Evotec SE (OTCMKTS:EVTCY – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $5.17 and last traded at $5.20, with a volume of 226635 shares. The stock had previously closed at $5.02.
Evotec Trading Up 3.6 %
The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The company has a market cap of $1.72 billion, a price-to-earnings ratio of 56.00 and a beta of 0.98. The business has a fifty day simple moving average of $7.28 and a 200 day simple moving average of $8.64.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
- Five stocks we like better than Evotec
- Russell 2000 Index, How Investors Use it For Profitable Trading
- The 3 Hottest Insiders Buys This Month
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Microsoft Analysis: Trends, Predictions & Investment Insight
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
